A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart

NCT02415400 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

4614

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Coronary Syndromes

Interventions

DRUG: Apixaban
DRUG: vitamin K antagonist
DRUG: Acetylsalicylic acid
OTHER: Acetylsalicylic acid placebo

Sponsor

Bristol-Myers Squibb

Collaborators

[object Object]
[object Object]